CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
Engage Prism (2.0)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05346055
NCT05346055N/ACompleted
CompareCT.gov

A Pilot Study of Delivering 'Engage' Psychotherapy Via Telemedicine Through the Tablet-based 'Prism' System to Homebound Older Adults With Depression

Weill Medical College of Cornell University·interventional·Posted Apr 26, 2022·Updated Jun 28, 2023

In Brief

A clinical study evaluating Engage Prism (2.0) for Depression. Completed, enrolled 8 participants across 1 site.

Detailed Summary

The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depressive symptoms. Eligible participants will be offered the combination of Engage and Prism 2.0, called Engage-Prism. The investigators hypothesize that the intervention (Engage Therapy With Video Support) will be accepted by participants, improve depressive symptom, and be feasible to complete.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 26, 2022
Enrollment StartMay 12, 2022
Primary CompletionSep 30, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 4.2 years ago

Interventions

Engage Prism (2.0)behavioral

Brief Behavioral Treatment for Depression (Engage) combined with tablet-based social support system (Prism 2.0)